Lateral Flow Assay Market Size is valued at USD 20.65 Bn in 2023 and is predicted to reach USD 24.45 Bn by the year 2031 at a 2.21% CAGR during the forecast period for 2024-2031.
Immunochromatographic tests, known as lateral flow assays, can determine if a target analyte, such as a pathogen or a biomarker, is present or absent in people or animals. Due to increased usage in medical diagnostics, a rise in the occurrence of infectious diseases, the increasing need for point-of-care testing, and the widespread acceptance of home-based lateral flow assay tests. In terms of sensitivity, selectivity, and quantification advancements, technological growth is causing lateral flow tests to work better. Manufacturers' test readers are frequently utilized to assess the robustness of a sample's test line. Portable lateral flow assay readers are becoming increasingly popular due to their expanding mobility and downsizing. Technological advancements in using various wavelengths for sample illumination and various sample detection systems, which use CMOS or CCD detecting technologies, are driving innovations in lateral flow assay testing equipment.
Furthermore, assays are evolving from straightforward qualitative tests to intricate multi-analyte quantitative assays, driving the growth of the lateral flow assay market. The substantial incidence of infectious diseases, the growing geriatric population, the rising demand for point-of-care testing, the rising demand for home-based lateral flow assay test kits, and the rising disposable income in developing nations are the main factors driving the global lateral flow assay market. The global market is expected to be driven by technological development and rising product usage. The demand for user-friendly point-of-care testing in-home care settings that can provide results in real-time (5-15 minutes) is rising due to the increased frequency of infectious and lifestyle diseases.
The Lateral Flow Assay market segmentation is on the basis of type, application, technique, sample type and end users. Based on type, the market is segmented as kits & reagents and lateral flow readers. As per the application, the market is divided into clinical testing, veterinary diagnostics, food safety & environment testing and drug development & quality testing. By technique, the market is segmented into sandwich assay, competitive assays and multiplex detection assays. According to sample type, the market is divided into Blood Samples, Urine Samples, Saliva Samples and Others Samples. The end users segmentation compriseshospitals & clinics, diagnostic laboratories, home care, pharmaceutical & biotechnology companies and other end users.
The kits & reagents category will hold a major share of the world lateral flow assay market in 2022 due to the spread of infectious diseases and the expanding usage of lateral flow kits in home care settings. To improve the creation of efficient and sensitive lateral flow test instruments, Newmarket participants are working together. As a result, the market is projected that the demand for lateral flow assays will expand throughout the projection period due to increased strategic collaborations to accelerate the development of lateral flow kits.
The sandwich assay technique segment is projected to grow rapidly in the global lateral flow assay market owing to growing concerns about the harmful effects of synthetic chemicals on the skin. Hence, with the growing popularity of bio-based beauty products and personal hygiene products, there is an increase in demand for lateral flow assay in the personal care sector, especially in countries such as the US, Germany, the UK, China, and India.
The North America lateral flow assay market is expected to record the maximum market share in revenue shortly. As the increase in chronic disease prevalence, the rise in requirement for home health care, the early adoption of test procedures, and the existence of many important stakeholders. In addition, Asia Pacific is estimated to grow rapidly in the global lateral flow assay market. Due to a huge patient pool, increased government initiatives to provide improved healthcare facilities, a growth in disposable money, and increased public knowledge.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 20.65 Bn |
| Revenue Forecast In 2031 | USD 24.45 Bn |
| Growth Rate CAGR | CAGR of 2.21% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, By Application, By Technique, By Sample Type, By End Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), PerkinElmer Inc. (U.S.), Quidel Corporation (U.S.), Merck KGAA (Germany), Abcam Plc, Surmodics, Inc., Chembio Diagnostics, Inc., Orasure Technologies, DCN Diagnostics, Polysciences Inc., Abingdon Health, Oranoxis Inc., Aesku.Group Gmbh, Bio Group Medical System S.R.L, Pharmact Gmbh, Diesse Diagnostica Senese S.P.A., Xiamen Biotime Biotechnology Co., Ltd. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Type-
Lateral Flow Assay Market By Application-
Lateral Flow Assay Market By Technique
Lateral Flow Assay Market By Sample type
Lateral Flow Assay Market By End Users
Lateral Flow Assay Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.